Hugh Beatty, M.D.
- PRP Therapy
- Shockwave Therapy
- Ozone Therapy
- Arthritis Treatment
- Erectile Dysfunction (ED) Treatment
Bakersfield, CA
Stem cell offers in Bakersfield sit between Downtown / Chester medical corridors and Stockdale / southwest cash-pay menus. Rosedale / northwest fringe calendars sometimes own consults that skip a tourist lobby pitch. Delano drive time changes who books the first evaluation, not the product math. Central Valley drive-time and oil-patch employer calendars change who books a consult more than LA spa menus. This hub is Bakersfield CA, not Los Angeles paste.
"Stem cell" on a menu can mean same-day bone marrow or adipose product, an allogeneic cord pitch, or an investigational protocol. Those are not one category. Ask what is actually delivered, how it is sourced, who performs the procedure, and what outcomes they track in writing. Kern River adjacency is geography only.
This hub lists Directory clinics for Bakersfield and stem cell therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
California SB 1004 (2017) requires written disclosure when a provider offers non-FDA-approved stem cell therapies. We omit invented city averages. Prefer plain risk talk. Use the national stem cell Directory and Guide, then return here.
Before you trust badges or counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
California cellular therapy providers are subject to 21 CFR Part 1271. Minimally manipulated human cells, tissues, and cellular and tissue-based products used for homologous use are regulated under Section 361 without premarket approval. Products that are more than minimally manipulated, used non-homologously, or combined with a drug or device are regulated as biologics under Section 351 and require an IND for clinical use or a BLA for marketing. Adipose-derived stromal vascular fraction, culture-expanded mesenchymal stem cells, and exosomes used for orthopedic, cosmetic, neurologic, and longevity indications are generally Section 351 products.
California has been a focal point of federal enforcement. In United States v California Stem Cell Treatment Center (2022), the Ninth Circuit upheld FDA authority to regulate stromal vascular fraction as a Section 351 drug, resulting in a permanent injunction against the clinic. The FDA has issued multiple warning letters to California providers marketing stem cell and exosome therapies. The Medical Board of California has disciplined physicians for false advertising under BPC 651 and for administering unapproved biologics. The California Department of Public Health enforces tissue bank licensing. Class-action consumer suits against regenerative clinics have produced settlements.
Available here
Nationwide
Stem Cell Therapy clinics across the US